Cizzle Biotechnology (LON:CIZ) Hits New 52-Week High – Here’s Why

Cizzle Biotechnology Holdings Plc (LON:CIZ)’s stock price reached a new 52-week high on Monday . The stock traded as high as GBX 2.90 and last traded at GBX 2.54, with a volume of 2405493 shares traded. The stock had previously closed at GBX 1.98.

Cizzle Biotechnology Price Performance

The stock’s 50 day simple moving average is GBX 1.58 and its 200-day simple moving average is GBX 1.58. The firm has a market cap of £8.82 million, a price-to-earnings ratio of -6.95 and a beta of 0.51. The company has a debt-to-equity ratio of -54.35, a quick ratio of 4.66 and a current ratio of 0.48.

Cizzle Biotechnology Company Profile

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.